Longboard Pharmaceuticals, Inc. (LBPH) Misses Q2 EPS by 12c

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q2 EPS of ($0.56), $0.12 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities